ArticleCell reports. Medicine2024

Discovery of galectin-8 as an LILRB4 ligand driving M-MDSCs defines a class of antibodies to fight solid tumors.

Yiting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.